Fibroscan and fibrosis-4 in recovered hepatitis C patients
World Journal of Gastroenterology · 14.08.2026 · 32 (30)
DOI: 10.3748/wjg.117164 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Gastroenterology, online erschienen am 14.08.2026. Verfasst von Nouhoum Bouare und 1 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben.
Abstract (Originalsprache)
The management of chronic hepatitis C, particularly focusing on patient follow-up after hepatitis C virus (HCV) cure, has been extensively documented. da Silva et al recently evaluated the prognostic value of liver stiffness measurements and the fibrosis-4 index at baseline and 1 year after HCV therapy with direct-acting antiviral. They aimed to predict hepatocellular carcinoma occurrence in patients with compensated advanced chronic liver disease who achieved a sustained viral response. This editorial comments on an article by da Silva et al published in a recent issue of the World Journal of Gastroenterology . We discuss da Silva et al ’s work in the context of patients who have recovered from hepatitis C, highlighting the current knowledge in the field and providing guidance. Articles from the Google Scholar database, PubMed, European Association for the Study of Liver and American Association for the Study of Liver Diseases guidelines, and other relevant databases and studies were used in this study.
Zitieren
APA
Bouare, N., & Delwaide, J. (2026). Fibroscan and fibrosis-4 in recovered hepatitis C patients. World Journal of Gastroenterology, 32(30). https://doi.org/10.3748/wjg.117164
Vancouver
Bouare N, Delwaide J. Fibroscan and fibrosis-4 in recovered hepatitis C patients. World Journal of Gastroenterology. 2026;32(30). doi:10.3748/wjg.117164
BibTeX
@article{Bouare2026,
author = {Bouare, Nouhoum and Delwaide, Jean},
title = {Fibroscan and fibrosis-4 in recovered hepatitis C patients},
journal = {World Journal of Gastroenterology},
year = {2026},
volume = {32},
number = {30},
doi = {10.3748/wjg.117164}
}
EUVIMED